by APFLI | Nov 12, 2006 | Regenerative Medicine
William Haseltine, CEO of Human Genome Sciences, is a leading advocate of embryonic stem cell research. But, he says results are decades away and his company is not spending money on the unproven cells. “The routine utilization of human embryonic stem cells for...
